The essentials of aerosol therapy: what the practicing physician should know

Symposium
Chairs: F. De Jongh (Enschede, Netherlands), P. Diot (Tours, France)
Aims: To inform ERS members of the outcome of the ISAM/ERS Task Force and to educate them in the limitations and benefits of aerosol delivery of medication.
This will appeal to members working in both primary and secondary care and will have implications for clinical trials and therapeutics.

Aerosol delivery overview B. Laube (Baltimore, United States of America)
Not all inhalers are the same: factors to consider when prescribing a new device inhaler H. Chrystyn (Huddersfield, United Kingdom)
Aerosol therapies for airway obstructive disorders at home and in the hospital (asthma, COPD, CF and non-CF disorders) R. Dhand (Columbia, United States of America)